Skip to main content
Erschienen in: Annals of Hematology 12/2007

01.12.2007 | Original Article

The clinical significance of non-malignant neutropenia in hospitalized children

verfasst von: Vasiliki Vlacha, Gavriella Feketea

Erschienen in: Annals of Hematology | Ausgabe 12/2007

Einloggen, um Zugang zu erhalten

Abstract

Neutropenia in non-cancer patients is often discovered in the course of an evaluation for acute infection, and it is usually secondary to the infection itself rather than a predisposing factor of the infection. Although it is not a common finding in hospitalized pediatric patients, it causes a great concern to the treating physicians. The aim of this study was to determine the incidence, the etiology, and the clinical significance of neutropenia in previously healthy children admitted in a general pediatric ward. One thousand five hundred and forty-eight patients admitted during a period of 18 months were included in the study. The clinical characteristics, the complete blood count, and the sedimentation rate were recorded. A total of 143 (9.2%) pediatric patients were identified as neutropenic, with mean absolute neutrophilic count of 0.960 × 109/l (SD 0.341 × 109/l) and ranged from 0.200 to 1.499 × 109/l. The neutropenic patients had lower hemoglobin of 11.2 mg/dl and ranged from 6.2 to 17.2 mg/dl compared to hemoglobin of 11.5 mg/dl, which ranged from 5.2 to 18.0 mg/dl of the individuals with normal neutrophils, p < 0.0001 and lower mean platelet count of 294 × 109/l, which ranged from 122 to 929 × 109/l compared to platelet count of 381 × 109/l, which ranged from 90–165 × 109/l of the individuals without neutropenia, p < 0.001. Additionally, those patients were significantly younger than the non-neutropenic ones. Infection was the most common cause of neutropenia, although none of them developed septicemia. The neutrophil count normalized in most of the patients before discharge. However, 12 (8.3%) of neutropenic patients were discharged with persistent findings. Two of those were finally diagnosed with autoimmune neutropenia. In conclusion, the acquired neutropenia in hospitalized patients without malignancy is mild to moderate. It has no influence on the clinical outcome. Importantly, it has short duration, and it is usually resolved before patient’s discharge.
Literatur
2.
Zurück zum Zitat Vesta KS, Medina PJ (2003) Valproic acid-induced neutropenia. Ann Pharmacother 37(6):819–821PubMedCrossRef Vesta KS, Medina PJ (2003) Valproic acid-induced neutropenia. Ann Pharmacother 37(6):819–821PubMedCrossRef
3.
Zurück zum Zitat Lindblad R, Rodjer S (1991) A case of severe pancytopenia caused by ibuprofen. J Intern Med 229(3):281–283PubMedCrossRef Lindblad R, Rodjer S (1991) A case of severe pancytopenia caused by ibuprofen. J Intern Med 229(3):281–283PubMedCrossRef
4.
Zurück zum Zitat Klein I, Levey GS (1984) Unusual manifestations of hypothyroidism. Arch Intern Med 144:123–128PubMedCrossRef Klein I, Levey GS (1984) Unusual manifestations of hypothyroidism. Arch Intern Med 144:123–128PubMedCrossRef
5.
Zurück zum Zitat Sloand E (2005) Hematologic complications of HIV infection. AIDS Rev 7(4):187–196PubMed Sloand E (2005) Hematologic complications of HIV infection. AIDS Rev 7(4):187–196PubMed
6.
Zurück zum Zitat Istomin V, Sade E, Grossman Z, Rudich H, Zudich H, Sofer O, Hassin D (2004) Agranulocytosis associated with parvovirus B19 infection in otherwise healthy patients. Eur J Intern Med 15(8):531–533PubMedCrossRef Istomin V, Sade E, Grossman Z, Rudich H, Zudich H, Sofer O, Hassin D (2004) Agranulocytosis associated with parvovirus B19 infection in otherwise healthy patients. Eur J Intern Med 15(8):531–533PubMedCrossRef
7.
Zurück zum Zitat Lehman HW, von Landenberg P, Modrow S (2003) Parvovirus B19 infection and autoimmune disease. Autoimmun Rev 2(4):218–223CrossRef Lehman HW, von Landenberg P, Modrow S (2003) Parvovirus B19 infection and autoimmune disease. Autoimmun Rev 2(4):218–223CrossRef
8.
Zurück zum Zitat Imashuku S, Hibi S, Kuriyama K, Tabata Y, Hashida T, Iwai A, Kato M, Yamashita N, Oda M, Uchida M, Kinugawa N, Sawada M, Konno M (2000) Management of severe neutropenia with cyclosporin during initial treatment of Epstein–Barr virus-related hemophagocytic lymphohistiocytosis. Leuk Lymphoma 36(3–4):339–346PubMedCrossRef Imashuku S, Hibi S, Kuriyama K, Tabata Y, Hashida T, Iwai A, Kato M, Yamashita N, Oda M, Uchida M, Kinugawa N, Sawada M, Konno M (2000) Management of severe neutropenia with cyclosporin during initial treatment of Epstein–Barr virus-related hemophagocytic lymphohistiocytosis. Leuk Lymphoma 36(3–4):339–346PubMedCrossRef
9.
Zurück zum Zitat Singh KJ, Ahluwalia G, Sharma SK, Saxena R, Chaudhary VP, Anant M (2001) Significance of haematological manifestations in patients with tuberculosis. J Assoc Phys India 49:788, 790–794 Singh KJ, Ahluwalia G, Sharma SK, Saxena R, Chaudhary VP, Anant M (2001) Significance of haematological manifestations in patients with tuberculosis. J Assoc Phys India 49:788, 790–794
10.
Zurück zum Zitat Nord JA, Kislak JW (2002) Profound neutropenia and atypical lymphocytosis in a traveller to Ghana. Int J Infect Dis 6(1):87–88PubMedCrossRef Nord JA, Kislak JW (2002) Profound neutropenia and atypical lymphocytosis in a traveller to Ghana. Int J Infect Dis 6(1):87–88PubMedCrossRef
11.
Zurück zum Zitat Chung BH, Chan GC, Lee TL, Kwok JS, Chiang AK, Ho HK, Ha SY, Lau YL (2004) Chronic benign neutropenia among Chinese children. 1. Hong Kong Med J 10(4):231–236PubMed Chung BH, Chan GC, Lee TL, Kwok JS, Chiang AK, Ho HK, Ha SY, Lau YL (2004) Chronic benign neutropenia among Chinese children. 1. Hong Kong Med J 10(4):231–236PubMed
12.
Zurück zum Zitat Bux J, Behrens G, Jaeger G, Welte K (1998) Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood 1; 91(1):181–186PubMed Bux J, Behrens G, Jaeger G, Welte K (1998) Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood 1; 91(1):181–186PubMed
13.
Zurück zum Zitat Smith MA, Smith JG (2002) Clinical experience with the use of rhG-CSF in secondary autoimmune neutropenia. Clin Lab Haematol 24(2):93–97PubMedCrossRef Smith MA, Smith JG (2002) Clinical experience with the use of rhG-CSF in secondary autoimmune neutropenia. Clin Lab Haematol 24(2):93–97PubMedCrossRef
14.
Zurück zum Zitat Bruin M, Dassen A, Pajkrt D, Buddelmeyer L, Kuijpers T, de Haas M (2005) Primary autoimmune neutropenia in children: a study of neutrophil antibodies and clinical course. Vox Sang 88(1):52–59PubMedCrossRef Bruin M, Dassen A, Pajkrt D, Buddelmeyer L, Kuijpers T, de Haas M (2005) Primary autoimmune neutropenia in children: a study of neutrophil antibodies and clinical course. Vox Sang 88(1):52–59PubMedCrossRef
15.
Zurück zum Zitat Capsoni F, Sarzi-Puttini P, Zanella A (2005) Primary and secondary autoimmune neutropenia. Arthritis Res Ther 7(5):208–214PubMedCrossRef Capsoni F, Sarzi-Puttini P, Zanella A (2005) Primary and secondary autoimmune neutropenia. Arthritis Res Ther 7(5):208–214PubMedCrossRef
16.
Zurück zum Zitat Palmblad J, Papadaki HA, Eliopoulos G (2001) Acute and chronic neutropenias. What is new? J Intern Med 250(6):476–491PubMedCrossRef Palmblad J, Papadaki HA, Eliopoulos G (2001) Acute and chronic neutropenias. What is new? J Intern Med 250(6):476–491PubMedCrossRef
17.
18.
Zurück zum Zitat Asmar BI, Maqbool S, Dajani AS (1981) Hematologic abnormalities after oral trimethoprim–sulfamethoxazole therapy in children. Am J Dis Child 135(12):1100–1103PubMed Asmar BI, Maqbool S, Dajani AS (1981) Hematologic abnormalities after oral trimethoprim–sulfamethoxazole therapy in children. Am J Dis Child 135(12):1100–1103PubMed
19.
Zurück zum Zitat Tantawichien T, Tungsanga K, Swasdikul D (1994) Reversible severe neutropenia after ceftriaxone. Scand J Infect Dis 26(1):109–110PubMed Tantawichien T, Tungsanga K, Swasdikul D (1994) Reversible severe neutropenia after ceftriaxone. Scand J Infect Dis 26(1):109–110PubMed
20.
Zurück zum Zitat Kumar K, Kumar A (1981) Reversible neutropenia associated with ampicillin therapy in pediatric patients. Drug Intell Clin Pharm 15(10):802–806PubMed Kumar K, Kumar A (1981) Reversible neutropenia associated with ampicillin therapy in pediatric patients. Drug Intell Clin Pharm 15(10):802–806PubMed
21.
22.
Zurück zum Zitat Malcolm L, Bridgden MD (1999) Clinical utility of the erythrocyte sedimentation rate. Am Fam Phys 60(5):1443–1454 Malcolm L, Bridgden MD (1999) Clinical utility of the erythrocyte sedimentation rate. Am Fam Phys 60(5):1443–1454
23.
Zurück zum Zitat Papadaki HA, Charoulakis NZ, Eliopoulos DG, Psyllaki M, Eliopoulos GD (2001) Patients with non-immune chronic idiopathic neutropenia syndrome have increased splenic volume on ultrasonography. Clin Lab Haematol 23(2):111–117PubMedCrossRef Papadaki HA, Charoulakis NZ, Eliopoulos DG, Psyllaki M, Eliopoulos GD (2001) Patients with non-immune chronic idiopathic neutropenia syndrome have increased splenic volume on ultrasonography. Clin Lab Haematol 23(2):111–117PubMedCrossRef
24.
Zurück zum Zitat Papadaki HA, Pontikoglou C, Eliopoulos DG, Pyrovolaki K, Spyridaki R, Eliopoulos GD (2006) Helicobacter pylori infection is probably the cause of chronic idiopathic neutropenia (CIN)-associated splenomegaly. Am J Hematol 81(2):142–144PubMedCrossRef Papadaki HA, Pontikoglou C, Eliopoulos DG, Pyrovolaki K, Spyridaki R, Eliopoulos GD (2006) Helicobacter pylori infection is probably the cause of chronic idiopathic neutropenia (CIN)-associated splenomegaly. Am J Hematol 81(2):142–144PubMedCrossRef
Metadaten
Titel
The clinical significance of non-malignant neutropenia in hospitalized children
verfasst von
Vasiliki Vlacha
Gavriella Feketea
Publikationsdatum
01.12.2007
Verlag
Springer-Verlag
Erschienen in
Annals of Hematology / Ausgabe 12/2007
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-007-0346-y

Weitere Artikel der Ausgabe 12/2007

Annals of Hematology 12/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.